Market Tracker

07/28 6:05pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.09
Data as of Jul 28
 -0.02 / -0.64%
Today’s Change
2.75
Today|||52-Week Range
5.50
-23.13%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.11
Today’s open3.09
Day’s range3.04 - 3.15
Volume54,290
Average volume (3 months)132,262
Market cap$70.5M
Dividend yield--
Data as of 4:00pm ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+16.15%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...-0.03-4.92%
CPXXCelator Pharmaceutic...-0.01-0.36%
CNDOCoronado Biosciences...-0.01-0.61%
OGENOragenics Inc-0.02-1.07%
Data as of 4:02pm ET, 07/28/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts